TipRanks
Go Ultimate55% OFF

Bart Filius Insider Profile

4 Followers

Bart Filius, Chief Financial Officer & Chief Operating Officer at Lakefront Biotherapeutics NV, holds ― shares in Lakefront Biotherapeutics NV (Ticker: GB:0JXZ). Most recently, Bart Filius Bought 10,000 shares of Lakefront Biotherapeutics NV on Dec 21, 2020 for an estimated value of €769.50K.

Bart Filius's Trading History

0JXZ
Lakefront Biotherapeutics NV
Dec 21, 2020Chief Financial Officer & Chief Operating OfficerInformative Buy769.50K―
GB:0JXZ
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 21, 2020Informative Buy€769.50K10,000€76.95-37.40%―
Dec 09, 2020Uninformative Sell€230.50K5,000€46.10――
Sep 22, 2020Uninformative Sell€230.50K5,000€46.10――
Jun 03, 2020Informative Sell€18.01M90,000€200.09+56.20%―
Jun 03, 2020Uninformative Sell€4.51M95,000€47.47――

You May Also Like

Bart Filius insider profile FAQ

What is the percentage of profitable transactions made by Bart Filius?
The percentage of profitable transactions made by Bart Filius is 36%.
What is the average return per transaction made by Bart Filius?
The average return per transaction made by Bart Filius is -17.70%.
What stocks does Bart Filius hold?
Bart Filius holds: GB:0JXZ stocks.
What was Bart Filius’s latest transaction?
Bart Filius’s latest transaction was an Informative Buy of €769.50K.
What was Bart Filius's most profitable transaction?
Bart Filius’s most profitable transaction was an Informative Sell of GB:0JXZ stock on June 3, 2020. The return on the trade was 56.20%.
What is Bart Filius's role in Lakefront Biotherapeutics NV?
Bart Filius's role in Lakefront Biotherapeutics NV is Chief Financial Officer & Chief Operating Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.